Emerging Industries

Industrial AI, energy systems, advanced materials, the low-altitude economy and synthetic biology currently sit in our framework as themes under continuous observation, not as an established strategy direction with defined investment criteria already in place. This distinction matters: observation means the research team invests time in understanding the technical path, industry-chain structure and potential demand sources, but it does not necessarily mean capital has entered or is about to. Conflating observation with commitment is a common starting point for misjudgment among capital operating in emerging fields — following a field's developments closely, and concluding that the field has reached conditions mature enough to invest in, are two separate decisions.

For themes on the watch list, the research team's working method differs from sector coverage under an already-established strategy: it relies more on direct exchanges with participants up and down the industry chain, ongoing mapping of where technical paths diverge, and close tracking of regulatory developments, rather than on public market information or third-party reports. This kind of research often produces no investment decision for years at a stretch. Its value lies in ensuring that once conditions genuinely mature, the team already has enough industry understanding to make a high-quality judgment the moment a window opens, rather than starting to learn an unfamiliar field from scratch.

Even once entry thresholds are met, uncertainty in an emerging field usually remains considerably higher than in a mature industry, which is why the initial position should stay restrained. We prefer to make a first entry at a small scale, sized so the position could be fully lost without disproportionate consequence, and then decide whether to add based on predefined validation checkpoints — customer renewal rates, or the actual trajectory of unit-cost decline, for example — rather than committing a large amount of capital in one step before conviction has been tested. This staged approach to sizing is, in essence, a way of converting uncertainty into a manageable, stage-released risk exposure, rather than an attempt to eliminate the uncertainty itself.

Our stance toward emerging industries is restraint rather than passive observation: we keep committing research resources to understand a field, while explicitly declining to deploy capital at meaningful scale until the three thresholds — customers, unit economics and regulatory path — are satisfied together. This stance sometimes means that after watching a theme discussed enthusiastically in the market for several years, we remain in the observation phase. That is not hesitation; it is what the method itself requires.

We believe that in a genuinely unfamiliar field, method is more reliable than prediction. No one can reliably judge in advance which frontier technology will ultimately outperform the alternatives, but a clear set of entry thresholds and a staged sizing discipline lets us move quickly, with sufficient industry understanding, once conditions mature — and lets us avoid taking on unnecessary risk prematurely, driven by market sentiment, when conditions have not. That method is itself the principal asset we bring to emerging industries.